CRVS Corvus Pharmaceuticals, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $897.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $146.3K | $0 |
| 2022-Q2 | $15.9K | $0 |
| 2022-Q3 | $35.3K | $0 |
| 2022-Q4 | $86.2K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $24.5K | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $1.0M | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $9.8M |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $333.7K | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $50.5K | $0 |
Bought$1.7M24 buy days
Sold$9.8M2 sell days
Net insider flow-$8.1Mnet selling · 5 years
Latest trade2026-11-13Arcara Jeffrey
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-13 | Buy | Arcara Jeffrey | Other C-suite | 1,003 | $10.54 | $10.6K | 2 |
| 2026-11-12 | Buy | Arcara Jeffrey | Other C-suite | 497 | $11.12 | $5.5K | 1 |
| 2026-11-11 | Buy | Arcara Jeffrey | Other C-suite | 3,000 | $11.46 | $34.4K | 1 |
| 2026-06-11 | Buy | Moore David Scott | Director | 21,700 | $11.53 | $250.2K | 1 |
| 2026-05-18 | Buy | MILLER RICHARD A MD | CEO | 6,932 | $12.04 | $83.5K | 2 |
| 2025-06-27 | Sell | ORBIMED ADVISORS LLC | Director | 1,176,332 | $4.16 | $4.9M | 1 |
| 2025-06-27 | Sell | Thompson Peter A. | Director | 1,176,332 | $4.16 | $4.9M | 1 |
| 2024-05-06 | Buy | MILLER RICHARD A MD | CEO | 577,634 | $1.73 | $999.3K | 1 |
| 2024-05-06 | Buy | Jones William Benton | Other officer | 20,000 | $1.73 | $34.6K | 1 |
| 2023-05-15 | Buy | Grais Linda | Director | 10,000 | $2.45 | $24.5K | 1 |
| 2022-12-20 | Buy | Jones William Benton | Other officer | 20,000 | $0.79 | $15.8K | 1 |
| 2022-12-14 | Buy | MILLER RICHARD A MD | CEO | 10,000 | $0.78 | $7.8K | 1 |
| 2022-12-14 | Buy | LEA LEIV | CFO | 4,000 | $0.84 | $3.4K | 1 |
| 2022-12-13 | Buy | MILLER RICHARD A MD | CEO | 50,000 | $0.74 | $37.0K | 1 |
| 2022-12-13 | Buy | LEA LEIV | CFO | 30,000 | $0.74 | $22.2K | 1 |
| 2022-09-28 | Buy | MILLER RICHARD A MD | CEO | 25,000 | $0.76 | $19.0K | 1 |
| 2022-09-20 | Buy | MILLER RICHARD A MD | CEO | 20,000 | $0.81 | $16.3K | 3 |
| 2022-06-27 | Buy | MILLER RICHARD A MD | CEO | 5,000 | $1.00 | $5.0K | 1 |
| 2022-06-24 | Buy | MILLER RICHARD A MD | CEO | 5,000 | $1.03 | $5.2K | 1 |
| 2022-06-06 | Buy | MILLER RICHARD A MD | CEO | 890 | $1.01 | $899 | 1 |
| 2022-06-02 | Buy | MILLER RICHARD A MD | CEO | 5,000 | $0.98 | $4.9K | 2 |
| 2022-03-31 | Buy | MILLER RICHARD A MD | CEO | 15,000 | $1.64 | $24.6K | 1 |
| 2022-03-17 | Buy | LEA LEIV | CFO | 13,878 | $1.65 | $22.9K | 1 |
| 2022-03-17 | Buy | MILLER RICHARD A MD | CEO | 5,000 | $1.59 | $8.0K | 1 |
| 2022-03-16 | Buy | LEA LEIV | CFO | 35,160 | $1.54 | $54.1K | 1 |
| 2022-03-15 | Buy | MILLER RICHARD A MD | CEO | 25,000 | $1.47 | $36.8K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director | $0 | $4.9M | 2025-06-27 |
| Thompson Peter A. | Director | $0 | $4.9M | 2025-06-27 |
| MILLER RICHARD A MD | CEO | $1.2M | $0 | 2026-05-18 |
| Moore David Scott | Director | $250.2K | $0 | 2026-06-11 |
| LEA LEIV | CFO | $102.6K | $0 | 2022-12-14 |
| Arcara Jeffrey | Other C-suite | $50.5K | $0 | 2026-11-13 |
| Jones William Benton | Other officer | $50.4K | $0 | 2024-05-06 |
| Grais Linda | Director | $24.5K | $0 | 2023-05-15 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-12-13 → 2022-12-20 | 3 | $86.2K | 51 | -7.1% (0.0% raw) | -12.8% (-13.9% raw) | +156.5% (+160.8% raw) | closed |
| 2021-02-17 | 3 | $9.3M | 60 | -19.4% (-22.3% raw) | -29.7% (-31.1% raw) | -48.4% (-51.6% raw) | closed |
| 2019-08-06 → 2019-08-07 | 3 | $1.0M | 61 | +10.6% (+11.7% raw) | -3.3% (+1.3% raw) | +21.4% (+31.2% raw) | closed |
| 2019-06-06 → 2019-07-01 | 4 | $5.1M | 69 | -7.7% (-8.8% raw) | – | +22.6% (+29.5% raw) | closed |
| 2018-03-12 | 6 | $30.8M | 66 | +7.0% (+3.9% raw) | +11.7% (+16.8% raw) | -14.5% (-6.7% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.